The Metabolic Vulnerability Index
JACC: Heart Failure · 2024-02 · 12 (2) · 290-300
DOI: 10.1016/j.jchf.2023.06.013 ↗Kurz gefasst
Metaanalyse in der Zeitschrift JACC: Heart Failure, 2024-02. Verfasst von Katherine M Conners und 12 weiteren Autor:innen. Beteiligte Einrichtung: Heart Disease Phenomics Laboratory, Epidemiology and Community Health Branch, National Heart, Lung, and Blood Institute, National Institutes of Healt…. Hauptthemen laut MEDLINE: Heart Failure. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, Intramural NIH HHS, National Heart, Lung, and Blood Institute.
Abstract (Originalsprache)
BACKGROUND: Inflammation and protein energy malnutrition are associated with heart failure (HF) mortality. The metabolic vulnerability index (MVX) is derived from markers of inflammation and malnutrition and measured by nuclear magnetic resonance spectroscopy. MVX has not been examined in HF. OBJECTIVES: The authors sought to examine the prognostic value of MVX in patients with HF. METHODS: The authors prospectively assembled a population-based cohort of patients with HF from 2003 to 2012 and measured MVX scores with a nuclear magnetic resonance scan from plasma collected at enrollment. Patients were divided into 4 MVX score groups and followed until March 31, 2021. RESULTS: The authors studied 1,382 patients (median age: 78 years; 48% women). The median MVX score was 64.6. Patients with higher MVX were older, more likely to be male, have atrial fibrillation, have higher NYHA functional class, and have HF duration of >18 months. Higher MVX was associated with mortality independent of Meta-analysis Global Group in Chronic Heart Failure score, ejection fraction, and other prognostic biomarkers. Compared to those with the lowest MVX, the HRs for MVX groups 2, 3, and 4 were 1.2 (95% CI: 0.9-1.4), 1.6 (95% CI: 1.3-2.0), and 1.8 (95% CI: 1.4-2.2), respectively (Ptrend < 0.001). Measures of model improvement document the added value of MVX in HF for classifying the risk of death beyond the Meta-analysis Global Group in Chronic Heart Failure score and other biomarkers. CONCLUSIONS: In this HF community cohort, MVX was strongly associated with mortality independently of established clinical factors and improved mortality risk classification beyond clinically validated markers. These data underscore the potential of MVX to stratify risk in HF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Heart Disease Phenomics Laboratory, Epidemiology and Community Health Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA.
- Office of Biostatistics Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA.
- Division of Epidemiology, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA.
- Lipoprotein Metabolism Laboratory, Translational Vascular Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA.
- LabCorp, Morrisville, North Carolina, USA.
- Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.
Förderung
- NIA NIH HHS
- Intramural NIH HHS
- National Heart, Lung, and Blood Institute
Zitieren
APA
Conners, K. M., Shearer, J. J., Joo, J., Park, H., Manemann, S. M., Remaley, A. T., Otvos, J. D., Connelly, M. A., Sampson, M., Bielinski, S. J., Wolska, A., Turecamo, S., & Roger, V. L. (2024). The Metabolic Vulnerability Index. JACC: Heart Failure, 12(2), 290-300. https://doi.org/10.1016/j.jchf.2023.06.013
Vancouver
Conners KM, Shearer JJ, Joo J, Park H, Manemann SM, Remaley AT, et al. The Metabolic Vulnerability Index. JACC: Heart Failure. 2024;12(2):290-300. doi:10.1016/j.jchf.2023.06.013
BibTeX
@article{Conners2024,
author = {Conners, Katherine M and Shearer, Joseph J and Joo, Jungnam and Park, Hoyoung and Manemann, Sheila M and Remaley, Alan T and Otvos, James D and Connelly, Margery A and Sampson, Maureen and Bielinski, Suzette J and Wolska, Anna and Turecamo, Sarah and Roger, Véronique L},
title = {The Metabolic Vulnerability Index},
journal = {JACC: Heart Failure},
year = {2024},
volume = {12},
number = {2},
pages = {290--300},
doi = {10.1016/j.jchf.2023.06.013}
}
EUVIMED